Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,271

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: MN ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 19, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India. NDC: 68180-518-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg, 1 Blister Pack Containing 28 Tablets, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1554-6

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Leader Nasal Decongestant PE (Phenylephrine HCl 10 mg), 18 Tablets per cartons, Distributed By Cardinal Health, Dublin, Ohio 43017. NDC: 70000-0126-1

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. NDC: 23155-002-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

FOLIC ACID TABLETS, USP, 1MG, 100 Tablets per bottle, Rx Only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004. NDC: 69315-127-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Fluticasone Propionate Nasal Spray USP, 50MCG per spray, 16 g net fill weight, 120 Metered Sprays, For Intranasal Use Only, Rx Only, Manufactured for: Apotext Corp., Weston, FL 33326. NDC: 60505-0829-1

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

FIRST LANSOPRAZOLE PT 3MG/ML, 300ML, Rx Only, Distributed By: CutisPharma, Inc., Woburn, MA 01801. NDC: 65628-080-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes per box, Rx Only, Sandoz Inc, Princeton, NJ 08540. NDC: 0781-3299-69

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Donepezil HCl Tablets, 5 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-275-09

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Donepezil HCl Tablets, 10 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-276-09

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Dicyclomine Hydrochloride Tablets, USP 20 mg, 100 Tablets, Rx only, Manufactured For: Teva Pharmaceuticals USA, Parsippany, NJ 07054. NDC: 0591-0795-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

Colgate Total SF Toothpaste, Net Wt 4.8 oz (136 g), Stannous Fluoride 0.454%, Clean Mint, Dist. by: COLGATE-PALMOLIVE CO., New York, NY 10022 USA

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 0378-6232-01

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 29, 2024Historical recordClass II

CHLORTHALIDONE Tablets, USP, 25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; Manufactured For: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. NDC: 43598-719-10

by CARDINAL HEALTHCARE

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Published: January 3, 2024
Distribution: Nationwide

View recall →

Data last updated: October 19, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.